Roche Executive and Leadership Team

Brigitte Nolet, the President & Chief Executive Officer, Roche Pharmaceuticals (Canada), directs the strategic growth and operational excellence of Roche's pharmaceutical business within Canada. Overseeing all commercial activities, Brigitte Nolet ensures the delivery of innovative medicines to Canadian patients, focusing on key therapeutic areas such as oncology and immunology. This executive role involves leading a dedicated team, fostering strong relationships with healthcare providers and stakeholders, and driving market access for critical treatments. Brigitte Nolet's leadership is instrumental in advancing Roche's mission of improving patient lives through personalized healthcare solutions tailored to the Canadian market. The strategic vision set by Brigitte Nolet guides the Canadian pharmaceutical division's efforts in research, development, and commercialization, reinforcing Roche's commitment to addressing unmet medical needs and enhancing healthcare outcomes across the nation.

Avi Danziger, the Chief Executive Officer, Roche (Israel), leads the strategic direction and operational execution of Roche's business within Israel. Overseeing both pharmaceutical and diagnostics operations, Avi Danziger drives innovation and market growth, ensuring access to advanced healthcare solutions for the Israeli population. This executive role involves managing key stakeholder relationships, fostering local partnerships, and adapting global strategies to meet regional needs. Avi Danziger's leadership focuses on enhancing patient outcomes through personalized healthcare and cutting-edge diagnostics. By championing Roche's mission in Israel, Avi Danziger plays a pivotal role in advancing medical science and improving the quality of life for individuals facing serious diseases. The CEO's commitment is central to Roche's impact in the region.

Katrin Heil, the Chief Financial Officer, Cluster Lead Finance & Operations, manages the financial health and operational efficiency for designated clusters at Roche. Overseeing all financial planning, reporting, and investment strategies, Katrin Heil ensures fiscal responsibility and supports sustainable growth across the organization. This executive position involves leading finance and operations teams, driving cost optimization initiatives, and providing strategic financial guidance to support business objectives. Katrin Heil's expertise is crucial in navigating complex financial landscapes and ensuring robust operational frameworks. By aligning financial strategies with operational imperatives, Katrin Heil contributes directly to Roche's ability to invest in groundbreaking research and development, ultimately advancing its mission to improve patient lives. The CFO's role is central to maintaining financial stability and enabling strategic expansion.

Farhan Bhatti, the Chief Financial Officer & Director, Finance, oversees the financial operations and strategic fiscal planning for key segments of Roche. Directing all financial activities, Farhan Bhatti ensures the integrity of financial reporting, manages budgets, and drives financial performance improvements. This executive role involves providing critical financial insights to support business decisions, optimizing resource allocation, and identifying opportunities for enhanced profitability and efficiency. Farhan Bhatti's expertise is vital in guiding the company's financial strategy, ensuring compliance with global financial regulations, and supporting investment in research and development. By maintaining a strong financial foundation, Farhan Bhatti enables Roche to continue its pioneering work in pharmaceuticals and diagnostics, ultimately contributing to its mission of improving patient outcomes worldwide. The CFO's strategic financial management is key to sustained innovation.

Maria del Pilar Camacho, the Director, Finance & Administrative & Chief Financial Officer, manages comprehensive financial and administrative functions for her designated areas within Roche. Overseeing financial planning, accounting, and administrative operations, Maria del Pilar Camacho ensures efficient resource management and adherence to fiscal policies. This leadership position involves providing strategic financial guidance, optimizing operational expenditures, and supporting the administrative infrastructure necessary for business success. Maria del Pilar Camacho's role is critical in maintaining financial discipline and operational effectiveness, enabling Roche to pursue its goals in healthcare innovation. By ensuring sound financial practices and efficient administrative support, Maria del Pilar Camacho contributes to the company's ability to deliver life-changing pharmaceutical and diagnostic solutions. The CFO's oversight supports the company's global mission.

Muhammad Noaman, the Chief Financial Officer (Vietnam), directs the financial strategy and operational fiscal management for Roche's operations in Vietnam. Overseeing all financial planning, reporting, and compliance, Muhammad Noaman ensures the financial integrity and sustainability of the business in the region. This key role involves providing strategic financial insights to support market growth, optimizing resource allocation, and managing budgets effectively. Muhammad Noaman's expertise is crucial for navigating the local financial landscape and supporting Roche's commitment to delivering innovative healthcare solutions. By maintaining robust financial controls and driving efficiency, Muhammad Noaman contributes significantly to Roche's mission of improving people's lives through advancements in pharmaceuticals and diagnostics within Vietnam. The CFO's financial acumen supports regional objectives.

Rajendra Dubey, the Chief Operating Officer, MH and Punjab Cluster, spearheads operational strategies and execution across these key regions for Roche. Overseeing the integration of pharmaceutical and diagnostic operations, Rajendra Dubey ensures efficient resource allocation and seamless service delivery to meet regional healthcare demands. This critical role involves managing supply chains, optimizing manufacturing processes, and driving business development initiatives to expand Roche's reach. Rajendra Dubey's leadership focuses on enhancing operational performance and ensuring compliance with regulatory standards across the MH and Punjab clusters. By fostering collaboration and implementing best practices, Rajendra Dubey contributes significantly to Roche's mission of improving people's lives through innovative healthcare solutions. The COO's oversight is vital for maintaining high standards of quality and accessibility in these important markets.

Mia Zhao, the Chief of Staff at Roche, directs strategic initiatives and operational alignment across key departments. Overseeing critical projects, Mia Zhao ensures seamless execution of corporate objectives, supporting the executive leadership team in driving Roche's mission forward. This role involves coordinating cross-functional efforts to enhance efficiency and foster innovation within the organization. Mia Zhao's focus remains on optimizing internal processes and facilitating communication to achieve strategic goals. The position demands a comprehensive understanding of Roche's global operations and its commitment to advancing science for better health outcomes. Mia Zhao's contributions are vital in translating high-level strategy into actionable plans, ensuring that all teams work cohesively towards the company's overarching vision of personalized healthcare and transforming patient care worldwide.

Robert McRuer, the Chief Technology Officer at Roche, architects the company's technological vision and digital transformation strategy. Overseeing all aspects of IT infrastructure and innovation, Robert McRuer drives the development and implementation of cutting-edge solutions that support Roche's pharmaceutical and diagnostics divisions. This leadership position involves managing global technology teams, ensuring robust cybersecurity measures, and exploring emerging technologies to enhance research, development, and operational efficiency. Robert McRuer's mandate includes leveraging data analytics and artificial intelligence to accelerate drug discovery and improve diagnostic accuracy. By fostering a culture of technological excellence, Robert McRuer ensures Roche remains at the forefront of healthcare innovation, delivering advanced solutions that improve people's lives. The CTO's strategic direction is crucial for maintaining Roche's competitive edge in a rapidly evolving scientific landscape.

Rebecca Laurin, the Governance & Strategic Alignment Leader & Chief of Staff at Roche, ensures robust corporate governance and aligns strategic initiatives across the organization. Overseeing the framework for decision-making and operational integrity, Rebecca Laurin facilitates effective communication between leadership and various business units. This multifaceted role involves managing key governance processes, driving strategic planning alignment, and supporting the executive team in achieving corporate objectives. Rebecca Laurin's focus is on enhancing organizational effectiveness and ensuring that all activities adhere to Roche's high standards of ethical conduct and strategic direction. By fostering clear governance structures and strategic coherence, Rebecca Laurin plays a vital part in advancing Roche's mission to improve people's lives through innovative healthcare solutions. The leadership provided by Rebecca Laurin is essential for maintaining operational discipline and strategic focus.